Diabetes Drug Jardiance Shows Heart Failure Benefits

Dapagliflozin Approved to Treat Heart Failure

Diabetes Drug Jardiance Shows Heart Failure Benefits

Jardiance (empagliflozin) has been studied for its use in people with heart failure. A study has found it shows effectiveness in patients with reduced ejection fraction (HFrEF). In heart failure with reduced ejection fraction, the heart muscle does not contract efficiently, and a smaller percentage of blood is pumped out of the heart than usual. Read more

Related

Posted in Drugs Medical Research

Via Source link